Learn More
Medchemexpress LLC trans-Nerolidol | 40716-66-3 | 50 MG

Supplier: Medchemexpress LLC HYN663550MG
trans-Nerolidol improves the anti-proliferative effect of Doxorubicin (DOX) against intestinal cancer and breast cancer cells in vitro. It increases the accumulation of DOX inside cells in vitro and activates apoptosis in vivo.
- Improves the anti-proliferative effect of doxorubicin (DOX) against intestinal cancer and breast cancer cells in vitro.
- Increases accumulation of doxorubicin (DOX) inside cells in vitro.
- Activates apoptosis in vivo.
- Purity: 96.24%
- Appearance: Liquid (density: 0.869±0.06 g/cm3)
- Color: Colorless to light yellow
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.